J Gen Virol Try IJSEM Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 68 (1987), 219-223; DOI 10.1099/0022-1317-68-1-219
© 1987 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pocchiari, M.
Right arrow Articles by Masullo, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pocchiari, M.
Right arrow Articles by Masullo, C.
Agricola
Right arrow Articles by Pocchiari, M.
Right arrow Articles by Masullo, C.

Amphotericin B Delays the Incubation Period of Scrapie in Intracerebrally Inoculated Hamsters

Maurizio Pocchiari, Susanne Schmittinger and Carlo Masullo

Istituto di Neurologia, Università Cattolica del S. Cuore, Largo Francesco Vito 1, 00168 Roma, Italy

The scrapie-infected hamster has been considered an excellent model for the study of slow virus diseases of man (Creutzfeldt-Jakob disease) and animals. At the moment no therapy is available for the cure of these fatal central nervous system diseases, although several drugs have been tested. We found that amphotericin B (AmB), a polyene antibiotic, increased the incubation time of scrapie disease in animals infected by either the intraperitoneal or intracerebral route. Hamsters inoculated with a 10% brain suspension of the 263K strain of scrapie showed clinical signs of disease in 54·6 ± 4·7 days. Under AmB treatment (1 mg/kg for 6 days a week) the incubation time increased with the length of treatment, up to a maximum delay of 45 days. AmB may interact with the scrapie agent on cell plasma membranes and may thereby decrease the rate of scrapie replication. However, AmB did not have any effect when administered after the clinical onset of scrapie disease.

Received 19 June 1986; accepted 10 September 1986.


This article has been cited by other articles:


Home page
BrainHome page
C. R Trevitt and J. Collinge
A systematic review of prion therapeutics in experimental models
Brain, September 1, 2006; 129(9): 2241 - 2265.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
D. A. Kocisko, W. S. Caughey, R. E. Race, G. Roper, B. Caughey, and J. D. Morrey
A Porphyrin Increases Survival Time of Mice after Intracerebral Prion Infection
Antimicrob. Agents Chemother., February 1, 2006; 50(2): 759 - 761.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. A. Kocisko and B. Caughey
Mefloquine, an Antimalaria Drug with Antiprion Activity In Vitro, Lacks Activity In Vivo
J. Virol., January 15, 2006; 80(2): 1044 - 1046.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Carmody, B. Murphy, B. Byrne, P. Power, D. Rai, B. Rawlings, and P. Caffrey
Biosynthesis of Amphotericin Derivatives Lacking Exocyclic Carboxyl Groups
J. Biol. Chem., October 14, 2005; 280(41): 34420 - 34426.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
A. Aguzzi and C. Haass
Games Played by Rogue Proteins in Prion Disorders and Alzheimer's Disease
Science, October 31, 2003; 302(5646): 814 - 818.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Barret, F. Tagliavini, G. Forloni, C. Bate, M. Salmona, L. Colombo, A. De Luigi, L. Limido, S. Suardi, G. Rossi, et al.
Evaluation of Quinacrine Treatment for Prion Diseases
J. Virol., August 1, 2003; 77(15): 8462 - 8469.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Forloni, S. Iussich, T. Awan, L. Colombo, N. Angeretti, L. Girola, I. Bertani, G. Poli, M. Caramelli, M. Grazia Bruzzone, et al.
Tetracyclines affect prion infectivity
PNAS, August 6, 2002; 99(16): 10849 - 10854.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
E. M. Sigurdsson, D. R. Brown, M. Daniels, R. J. Kascsak, R. Kascsak, R. Carp, H. C. Meeker, B. Frangione, and T. Wisniewski
Immunization Delays the Onset of Prion Disease in Mice
Am. J. Pathol., July 1, 2002; 161(1): 13 - 17.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Enari, E. Flechsig, and C. Weissmann
Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody
PNAS, July 19, 2001; (2001) 151242598.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Mangé, N. Nishida, O. Milhavet, H. E. M. McMahon, D. Casanova, and S. Lehmann
Amphotericin B Inhibits the Generation of the Scrapie Isoform of the Prion Protein in Infected Cultures
J. Virol., April 1, 2000; 74(7): 3135 - 3140.
[Abstract] [Full Text]


Home page
ScienceHome page
S. A. Priola, A. Raines, and W. S. Caughey
Porphyrin and Phthalocyanine Antiscrapie Compounds
Science, February 25, 2000; 287(5457): 1503 - 1506.
[Abstract] [Full Text]


Home page
J. Gen. Virol.Home page
L. lngrosso, F. Pisani, and M. Pocchiari
Transmission of the 263K scrapie strain by the dental route
J. Gen. Virol., November 1, 1999; 80(11): 3043 - 3047.
[Abstract] [Full Text]


Home page
J. Virol.Home page
R. Demaimay, R. Race, and B. Chesebro
Effectiveness of Polyene Antibiotics in Treatment of Transmissible Spongiform Encephalopathy in Transgenic Mice Expressing Syrian Hamster PrP Only in Neurons
J. Virol., April 1, 1999; 73(4): 3511 - 3513.
[Abstract] [Full Text]


Home page
J. Gen. Virol.Home page
K. Adjou, R Demaimay, J. Deslys, C. Lasmezas, V Beringue, S Demart, F Lamoury, M Seman, and D Dormont
MS-8209, a water-soluble amphotericin B derivative, affects both scrapie agent replication and PrPres accumulation in Syrian hamster scrapie
J. Gen. Virol., April 1, 1999; 80(4): 1079 - 1085.
[Abstract]


Home page
J. Biol. Chem.Home page
S. Caspi, M. Halimi, A. Yanai, S. B. Sasson, A. Taraboulos, and R. Gabizon
The Anti-prion Activity of Congo Red. PUTATIVE MECHANISM
J. Biol. Chem., February 6, 1998; 273(6): 3484 - 3489.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
F. Tagliavini, R. A. McArthur, B. Canciani, G. Giaccone, M. Porro, M. Bugiani, P. M. Lievens, O. Bugiani, E. Peri, P. Dall'Ara, et al.
Effectiveness of Anthracycline Against Experimental Prion Disease in Syrian Hamsters
Science, May 16, 1997; 276(5315): 1119 - 1121.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Enari, E. Flechsig, and C. Weissmann
Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody
PNAS, July 31, 2001; 98(16): 9295 - 9299.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1987 by the Society for General Microbiology.